Home NDC 0049-2330-79 NDC 0049-2330-79 - Relpax This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0049-2330
Requested NDC 0049-2330-79
Package NDCs from labels 0049-2330-79, 0049-2330-45
Manufacturer ROERIG
Effective date 2020-03-11
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Relpax - ROERIG ROERIG 2020-03-11 HUMAN PRESCRIPTION DRUG LABEL
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0049-2330-45 Relpax 6 in 1 CARTON TABLET, FILM COATED 6 25 0049-2330-79 Relpax 1 in 1 BLISTER PACK TABLET, FILM COATED 1 25
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0049-2330 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 24 Legacy NDC, 2 package rows 20250510_85745375-fcb6-4edc-b6db-a77b4a5f3e8c.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ELETRIPTAN HYDROBROMIDE ACTIVE INGREDIENT M41W832TA3 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 ELETRIPTAN ACTIVE MOIETY 22QOO9B8KI RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 LACTOSE INACTIVE INGREDIENT J2B2A4N98G RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG] 13
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 110 · 2,194 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.